BarbaraHMcGovernMD
Internal Medicine • Jamaica Plain, MAInfectious Disease
Associate Professor, Medicine, Tufts Medical Center
Are you Dr. McGovern?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 56 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
170 Morton St
Jamaica Plain, MA 02130Phone+1 617-971-3621Fax+1 617-971-3853- Is this information wrong?
Summary
- Dr. Barbara McGovern, MD is an internist in Jamaica Plain, Massachusetts. She is currently licensed to practice medicine in Massachusetts. She is an Associate Professor at Tufts Medical Center.
Education & Training
Tufts Medical CenterFellowship, Infectious Disease, 1992 - 1995- Tufts Medical CenterResidency, Internal Medicine, 1988 - 1991
Albert Einstein College of MedicineClass of 1988
Certifications & Licensure
MA State Medical License 1991 - 2016
Publications & Presentations
PubMed
- 41 citationsA Phase 1b Safety Study of SER-287, a Spore-Based Microbiome Therapeutic, for Active Mild to Moderate Ulcerative ColitisMatthew R. Henn, Edward J. O’Brien, Liyang Diao, Brian G. Feagan, William J. Sandborn, Curtis Huttenhower, Jennifer R. Wortman, Barbara H. McGovern, Sherry Wang-Weigan...> ;Gastroenterology. 2021 Jan 1
- 25 citationsThe Efficacy and Safety of Fecal Microbiota Transplant for Recurrent Clostridium difficile Infection: Current Understanding and Gap Analysis.Mark H. Wilcox, Barbara H. McGovern, Gail Hecht> ;Open Forum Infectious Diseases. 2020 Apr 11
- 88 citationsSER-109, an Investigational Microbiome Drug to Reduce Recurrence After Clostridioides difficile Infection: Lessons Learned From a Phase 2 Trial.Barbara H. McGovern, Christopher B. Ford, Matthew R. Henn, Darrell S. Pardi, Sahil Khanna, Elizabeth L. Hohmann, Edward J. O’Brien, Christopher A. Desjardins, Patricia...> ;Clinical Infectious Diseases. 2021 Jun 15
- Join now to see all
Press Mentions
Oral Microbiome Therapy for Recurrent C. Diff Mostly Holds up at 6 MonthsOctober 21st, 2022- Seres Therapeutics to Present Clinical Results at IDWeek and American College of Gastroenterology (ACG) 2022 Annual MeetingOctober 12th, 2022
Public Health Surveillance System May Seriously Underestimate Cases of Acute Hepatitis C InfectionJune 29th, 2015
